The dna and gene chip global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
DNA And Gene Chip Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The dna and gene chip market size has grown rapidly in recent years. It will grow from $7.38 billion in 2023 to $8.4 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to genomic research advancements, rise of personalized medicine, human genome project milestones, drug discovery and development, disease biomarker identification.
The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $13.7 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to advancements in precision medicine, expansion of biomarker discovery, growth of personalized therapeutics, application in cancer research, increasing research funding. Major trends in the forecast period include technological advancements, product innovations, regulatory framework and compliance, focus on rare diseases, continuous reduction in costs.
Order your report now for swift delivery @
Scope Of DNA And Gene Chip Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
DNA And Gene Chip Market Overview
Market Drivers –
The rising demand for early cancer detection is significantly contributing to the growth of the DNA and gene market. Cancer is a broad class of conditions that can develop in practically any organ or tissue of the body when aberrant cells multiply uncontrollably, cross normal cell boundaries to invade nearby organs, and spread to other regions of the body. DNA and gene chips are used to measure gene expression patterns, determine the genetic and epigenetic landscape, and measure genomic regulatory elements bound by cancer transcription factors in cancerous cells. For instance, in 2022, according to the American Cancer Society, a US-based community-based, voluntary health organization, it is projected that there will be approximately 1.9 million newly diagnosed cancer cases and 609,360 deaths from cancer in the United States. Therefore, rising demand for early cancer detection is driving the growth of the DNA and gene chip market.
Market Trends –
Strategic partnerships and collaborations are the key trends gaining popularity in the DNA and gene chip market. Many companies operating in this sector looking for partnerships to strengthen their position in the DNA and gene chip market. For instance, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, entered into a four-year strategic partnership with Wipro Limited, an India-based information technology company. Through this partnership, both companies execute the project titled Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer project-related genomics sequencing services. Further, in May 2022, Thermo Fisher Scientific, a US-based supplier of analytical instruments, partnered with Qatar Genome Program (QGP), a member of Qatar Foundation (QF)to develop an Axiom custom genotyping array for pan-Arab populations, utilizing whole genome sequencing data from 19 Arab countries. The array, with 800,000 variants, aims to enhance genomic research, focusing on conditions such as diabetes, cardiovascular diseases, autism, and cancer. The collaboration supports Qatar’s national vision for improved population health and the advancement of precision medicine for people of Arab identity worldwide. Thermo Fisher’s Axiom microarray technology facilitates accelerated precision medicine initiatives.
The dna and gene chip market covered in this report is segmented –
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users
Get an inside scoop of the dna and gene chip market, Request now for Sample Report @
Regional Insights –
North America was the largest region in the DNA and gene chip market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the dna and gene chip market report are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Affymetrix Inc., Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., Arrayit Corporation, BioChain Institute Inc., Cepheid, Clontech Laboratories Inc., Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences, Luminex Corporation
1. Executive Summary
2. DNA And Gene Chip Market Report Structure
3. DNA And Gene Chip Market Trends And Strategies
4. DNA And Gene Chip Market – Macro Economic Scenario
5. DNA And Gene Chip Market Size And Growth
…..
27. DNA And Gene Chip Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Twitter: https://twitter.com/tbrc_info
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
